Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Ostomy Drainage Bags Devices Market

ID: MRFR/HC/50911-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026

Germany Ostomy Drainage Bags Devices Market Research Report By Product Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Ileostomy Bags, Continent Urostomy Bags), By Procedure (Colostomy, Urostomy, Ileostomy), By Usage (Reusable, Disposable), By System Type (One-piece System, Two-piece System) and By End User (Hospitals, Clinics, Ambulatory Surgical Centres, Homecare, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Germany Ostomy Drainage Bags Devices Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Colostomy
  50.     4.1.2 Ileostomy
  51.     4.1.3 Urostomy
  52.     4.1.4 Continent Ostomy
  53.   4.2 Healthcare, BY End Use (USD Million)
  54.     4.2.1 Hospitals
  55.     4.2.2 Home Care
  56.     4.2.3 Ambulatory Surgical Centers
  57.   4.3 Healthcare, BY Material Type (USD Million)
  58.     4.3.1 Plastic
  59.     4.3.2 Silicone
  60.     4.3.3 Hydrocolloid
  61.     4.3.4 Foam
  62.   4.4 Healthcare, BY Drainage Type (USD Million)
  63.     4.4.1 Closed Drainage
  64.     4.4.2 Open Drainage
  65.     4.4.3 Continuous Drainage
  66.   4.5 Healthcare, BY Product Type (USD Million)
  67.     4.5.1 One-Piece System
  68.     4.5.2 Two-Piece System
  69.     4.5.3 Drainable Bags
  70.     4.5.4 Non-Drainable Bags
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Healthcare
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 Coloplast A/S (DK)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 Hollister Incorporated (US)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 B. Braun Melsungen AG (DE)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 Convatec Group PLC (GB)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 Smith & Nephew PLC (GB)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 Medtronic PLC (IE)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 Fresenius Kabi AG (DE)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 3M Company (US)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.   5.3 Appendix
  136.     5.3.1 References
  137.     5.3.2 Related Reports
  138. 6 LIST OF FIGURES
  139.   6.1 MARKET SYNOPSIS
  140.   6.2 GERMANY MARKET ANALYSIS BY APPLICATION
  141.   6.3 GERMANY MARKET ANALYSIS BY END USE
  142.   6.4 GERMANY MARKET ANALYSIS BY MATERIAL TYPE
  143.   6.5 GERMANY MARKET ANALYSIS BY DRAINAGE TYPE
  144.   6.6 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
  145.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  146.   6.8 RESEARCH PROCESS OF MRFR
  147.   6.9 DRO ANALYSIS OF HEALTHCARE
  148.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  149.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  150.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  151.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  152.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  153.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  154.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  155.   6.17 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
  156.   6.18 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
  157.   6.19 HEALTHCARE, BY DRAINAGE TYPE, 2024 (% SHARE)
  158.   6.20 HEALTHCARE, BY DRAINAGE TYPE, 2024 TO 2035 (USD Million)
  159.   6.21 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  160.   6.22 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  161.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  162. 7 LIST OF TABLES
  163.   7.1 LIST OF ASSUMPTIONS
  164.     7.1.1
  165.   7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  166.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  167.     7.2.2 BY END USE, 2026-2035 (USD Million)
  168.     7.2.3 BY MATERIAL TYPE, 2026-2035 (USD Million)
  169.     7.2.4 BY DRAINAGE TYPE, 2026-2035 (USD Million)
  170.     7.2.5 BY PRODUCT TYPE, 2026-2035 (USD Million)
  171.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  172.     7.3.1
  173.   7.4 ACQUISITION/PARTNERSHIP
  174.     7.4.1

Germany Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Colostomy
  • Ileostomy
  • Urostomy
  • Continent Ostomy

Healthcare By End Use (USD Million, 2026-2035)

  • Hospitals
  • Home Care
  • Ambulatory Surgical Centers

Healthcare By Material Type (USD Million, 2026-2035)

  • Plastic
  • Silicone
  • Hydrocolloid
  • Foam

Healthcare By Drainage Type (USD Million, 2026-2035)

  • Closed Drainage
  • Open Drainage
  • Continuous Drainage

Healthcare By Product Type (USD Million, 2026-2035)

  • One-Piece System
  • Two-Piece System
  • Drainable Bags
  • Non-Drainable Bags

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions